Direct-Abdominal chemo tested for incurable cancer
NCT ID NCT05449366
Summary
This study tested a new way to give chemotherapy to patients with a rare and aggressive abdominal cancer called malignant peritoneal mesothelioma. For patients who could not have major surgery, doctors delivered the drug paclitaxel directly into the abdomen through a small port. The main goals were to find the safest, most effective dose and to see if this approach was manageable for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL MALIGNANT MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Erasmus Medical Center
Rotterdam, South Holland, 3000 CA, Netherlands
Conditions
Explore the condition pages connected to this study.